Swiss exports to US surge in September as pharma shipments rise ahead of tariff threat

Group 1 - Swiss exports to the United States saw a significant rebound in September, with a nearly 43% increase in nominal terms compared to the previous month [1] - Overall Swiss exports increased by 3.4% in September [1] - The pharmaceutical sector played a crucial role in this rebound, as companies ramped up shipments ahead of potential tariffs [1] Group 2 - In August, U.S. President Donald Trump imposed 39% tariffs on Switzerland, leading to a sharp decline in exports that month [2] - Pharmaceutical companies were initially exempt from these tariffs, but a 100% tariff on branded or patented pharmaceutical products was threatened unless companies established manufacturing plants in the U.S. [2] - Major Swiss pharmaceutical companies like Roche and Novartis do not expect these tariffs to affect them due to their expansion plans in the U.S. [3] Group 3 - Adjusted for seasonal variations, Swiss exports of chemical and pharmaceutical products rose by 5.1% in September compared to the previous month, representing over half of all Swiss goods exports [3]